Adenosine A3 receptor expression and function in eosinophils
- PMID: 9160835
- DOI: 10.1165/ajrcmb.16.5.9160835
Adenosine A3 receptor expression and function in eosinophils
Abstract
The A3 adenosine receptor is widely expressed in human tissues with the most abundant expression in the lung and liver, but the predominant cellular localization and functions of this receptor in humans are unknown. Since adenosine influences the activation of circulating and resident inflammatory cells within the lung and leads to exaggerated airway narrowing in individuals with inflammatory airway disorders, we hypothesized that A3 receptor gene expression is localized to inflammatory cells and that gene expression is upregulated in airway inflammation. Lung and airway tissue were obtained at thoracotomy from nonsmoking subjects and subjects with inflammatory airway disorders associated with tobacco smoke or asthma. In situ hybridization identified A3 receptors in mesenchymal cells and eosinophils within the lamina propria of the airways and the adventitia of blood vessels, but not in mast cells. A3 receptor transcripts were highly expressed in peripheral blood eosinophils purified from atopic donors (6.36 +/- 0.60 pg/microg total RNA) in comparison with neutrophils (0.26 +/- 0.06 pg/microg) or mononuclear cells (0.9 +/- 0.15 pg/microg). Mean A3 receptor transcript abundance was greater in lung tissue from subjects with airway inflammation (0.33 +/- 0.04 pg/microg total RNA) than in normal lung (0.24 +/- 0.03 pg/microg total RNA, P = 0.035). The A3 receptor agonist N6-(4-amino-3-iodobenzyl)adenosine dose-dependently inhibited platelet activating factor-induced eosinophil chemotaxis to a maximum of 41%. This inhibitory effect was completely abolished by addition of the A3 receptor selective antagonist 3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine. We conclude that A3 receptors are primarily expressed on eosinophils in human lung, where they mediate inhibition of eosinophil chemotaxis. Specific A3 receptor ligands may be useful agents in the treatment of eosinophil-dependent diseases such as asthma and rhinitis.
Similar articles
-
A(3) adenosine receptor ligands: history and perspectives.Med Res Rev. 2000 Mar;20(2):103-28. doi: 10.1002/(sici)1098-1128(200003)20:2<103::aid-med1>3.0.co;2-x. Med Res Rev. 2000. PMID: 10723024 Review.
-
Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.Br J Pharmacol. 1999 May;127(1):188-94. doi: 10.1038/sj.bjp.0702476. Br J Pharmacol. 1999. PMID: 10369472 Free PMC article.
-
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.Mol Pharmacol. 1993 Sep;44(3):524-32. Mol Pharmacol. 1993. PMID: 8396714
-
Molecular cloning and characterization of the human A3 adenosine receptor.Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9. doi: 10.1073/pnas.90.21.10365. Proc Natl Acad Sci U S A. 1993. PMID: 8234299 Free PMC article.
-
Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.Trends Pharmacol Sci. 1994 Aug;15(8):298-306. doi: 10.1016/0165-6147(94)90011-6. Trends Pharmacol Sci. 1994. PMID: 7940998 Review.
Cited by
-
Extrahelical Binding Site for a 1H-Imidazo[4,5-c]quinolin-4-amine A3 Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7.Mol Pharmacol. 2024 Feb 15;105(3):213-223. doi: 10.1124/molpharm.123.000784. Mol Pharmacol. 2024. PMID: 38182432 Free PMC article.
-
Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression.J Med Chem. 2023 Aug 24;66(16):11399-11413. doi: 10.1021/acs.jmedchem.3c00854. Epub 2023 Aug 2. J Med Chem. 2023. PMID: 37531576 Free PMC article.
-
Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein Activation.ACS Pharmacol Transl Sci. 2022 Jul 15;5(8):625-641. doi: 10.1021/acsptsci.2c00076. eCollection 2022 Aug 12. ACS Pharmacol Transl Sci. 2022. PMID: 35983277 Free PMC article.
-
Eosinophils and Purinergic Signaling in Health and Disease.Front Immunol. 2020 Jul 8;11:1339. doi: 10.3389/fimmu.2020.01339. eCollection 2020. Front Immunol. 2020. PMID: 32733449 Free PMC article. Review.
-
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.Cells. 2020 Mar 24;9(3):785. doi: 10.3390/cells9030785. Cells. 2020. PMID: 32213945 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources